Reference number : 236-2016-2017-Q2-00041, amendment number : , agreement type : G, recipient legal name : Barbier, Olivier, recipient country : CA, recipient province : QC, recipient city : Québec, recipient postal code : G1K 7P4, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 516036.0, agreement start date : 2016-07-01, agreement end date : 2020-06-30, description english : Therapeutic potential of obeticholic acid for the treatment of advanced prostate cancer, description french : Therapeutic potential of obeticholic acid for the treatment of advanced prostate cancer, expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year.
(2016-17 to 2020-21), additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier.
(2016-17 à 2020-21), owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada